新诊断2型糖尿病患者胰岛素抵抗与心衰及死亡风险增加相关:UKPDS 89
本研究基于UKPDS队列中5102例新诊断2型糖尿病患者(其中4344例有HOMA2-IR测量),评估胰岛素抵抗与心衰或死亡复合结局及单纯心衰的关联。中位随访16.4年期间,共发生1974例(45.4%)心衰/死亡事件。多变量分析显示,HOMA2-IR翻倍与心衰/死亡风险增加5%(RR 1.05,95%CI 1.01-1.12,P=0.0029)及心衰风险增加14%(RR 1.14,95%CI 1.02-1.27,P=0.017)独立相关。
要点
- 新诊断2型糖尿病患者中,胰岛素抵抗程度越高,心衰或死亡风险越高。
- HOMA2-IR翻倍与心衰/死亡风险增加5%、心衰风险增加14%独立相关。
- 年龄、BMI、FPG、腰臀比、收缩压、LDL-C、心率等亦与心衰/死亡独立相关。
核心结论
- 新诊断2型糖尿病患者中,胰岛素抵抗与心衰或死亡复合结局及单纯心衰风险增加独立相关。
研究设计与样本
- 基于UKPDS前瞻性队列研究,纳入5102例新诊断2型糖尿病患者,其中4344例有HOMA2-IR测量值。
- 采用Kaplan-Meier生存曲线和多变量生存模型分析HOMA2-IR与心衰/死亡或单纯心衰的关联,调整单变量P<0.1且多变量P<0.05的变量。
主要发现
- 中位随访16.4年,共发生1974例(45.4%)心衰/死亡事件,包括235例首次心衰事件和1739例死亡。
- 入组时平均(SD)年龄52.5(8.7)岁,HbA1c 7.2%(1.8%),BMI 28.8(5.5)kg/m2,HOMA2-IR中位数(四分位距)1.6(1.1-2.2)。
- HOMA2-IR翻倍与心衰/死亡风险增加5%相关(RR 1.05,95%CI 1.01-1.12,P=0.0029)。
- HOMA2-IR翻倍与心衰风险增加14%相关(RR 1.14,95%CI 1.02-1.27,P=0.017)。
- 与心衰/死亡独立相关的因素还包括年龄、BMI、FPG、腰臀比、收缩压、LDL胆固醇、心率、性别、种族、吸烟状态、既往房颤和既往微量白蛋白尿。
临床怎么用
- 对新诊断2型糖尿病患者,评估胰岛素抵抗可能有助于识别心衰和死亡高风险个体。
- 在管理新诊断2型糖尿病时,除血糖外还应关注BMI、血压、血脂等与心衰/死亡独立相关的因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Insulin resistance (IR) may mediate heart failure (HF) development. We examined whether IR in people with newly diagnosed type 2 diabetes (T2D) increased their risk of a composite outcome of HF or death or of HF alone. RESEARCH DESIGN AND METHODS: Insulin resistance (HOMA2-IR) values for UKPDS participants were derived from paired fasting plasma glucose (FPG) and insulin measures. Kaplan-Meier survival curves and multivariable survival models were used to evaluate associations between HOMA2-IR and HF/death or HF alone. We adjusted for potential confounders by including variables with univariate associations (P < 0.1) and by requiring a multivariable P < 0.05. RESULTS: Of 5,102 UKPDS participants with newly diagnosed T2D, 4,344 had HOMA2-IR measurements. At enrollment, mean (SD) age was 52.5 (8.7) years, with HbA1c 7.2% (1.8%), and BMI 28.8 (5.5) kg/m2, and median (interquartile range) HOMA2-IR was 1.6 (1.1-2.2). HF/death occurred in 1,974 (45.4%) participants (235 first HF events, 1,739 deaths) over a median follow-up of 16.4 years. Multivariable independent associations with HF/death were older age and higher BMI, HOMA2-IR, FPG, waist-to-hip ratio, systolic blood pressure, LDL cholesterol, and heart rate as well as sex, race, smoking status, prior atrial fibrillation, and prior microalbuminuria. A doubling of HOMA2-IR was associated with a 5% greater risk of HF/death (relative risk [RR] 1.05 [95% CI 1.01-1.12], P = 0.0029) and a 14% greater risk of HF (RR 1.14, [95% CI 1.02-1.27], P = 0.017). CONCLUSIONS: Patients with newly diagnosed T2D and insulin resistance were more likely to develop HF or die than those more sensitive to insulin.
引用
- Wamil M, Coleman RL, Adler AI, et al. Increased Risk of Incident Heart Failure and Death Is Associated With Insulin Resistance in People With Newly Diagnosed Type 2 Diabetes: UKPDS 89. Diabetes Care. 2021. PMID: 34162666. doi:10.2337/dc21-0429
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。